Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus

BMC Medical Genetics

Volumn 2, Issue , 2001, Pages

  Chistyakov, Dimitry A ^a   Savost'anov, Kirill V ^b   Zotova, Elena V ^b   Nosikov, Valery V ^b  

^a l'alimentation et l'Environnement   (France)

^b STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTIOXIDANT; ARGININE; FREE RADICAL; GLYCINE; ISOLEUCINE; PEROXIDE; PRIMER DNA; SUPEROXIDE DISMUTASE; THREONINE; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; EXTRACELLULAR MATRIX; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; OXIDATIVE STRESS; PATHOGENESIS; POLYMERASE CHAIN REACTION; RESTRICTION SITE; RUSSIAN FEDERATION;

EID: 0002969524     PISSN: 14712350     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2350-2-4     Document Type: Article

References (33)

1. Hunt JV, Wolff SP: Oxidative glycation and free radical production: a causal mechanism of diabetic complications. Free Radic Res Commun 1991, 12-13:115-123
2. Low PA, Nickander KK, Tritschler HJ: The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997, 46:S38-S42
3. Zhu M, Spink DC, Yan B, Bank S , DeCaprio AP: Formation and structure of cross-linking and monomeric pyrrole autoxidation products in 2,5-hexanedione-treated amino acids, peptides, and protein. Chem Res Toxicol 1994, 7:551-558
4. Cameron NE, Cotter MA: Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 1997, 46:S31-37
5. Nagamatsu M., Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA: Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995, 18:1160-1167
6. Van Dam PS, Van Asbeck BS, Bravenboer B, Van Oirschot JF, Marx JJ, Gispen WH: Nerve conduction and antioxidant levels in experimentally diabetic rats: effects of streptozotocin dose and diabetes duration. Metabolism 1999, 48:442-447
7. Martinez-Blasco A, Bosch-Morell F, Trenor C, Romero FJ: Experimental diabetic neuropathy: role of oxidative stress and mechanisms involved. Biofactors 1998, 8:41-43
8. Yan H, Harding JJ: Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase. Biochem J 1997, 328:599-605
9. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizino Y: Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem Biophys Res Commun 1996, 226:561-565
10. Rosenblum JS, Gilula NB, Lerner RA: On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad. Sci USA 1996, 93:4471-4473
11. Hori H, Ohmori O, Shinkai T, Kojima H, Okano C, Suzuki T, Nakamura J: Manganese superoxide dismutase gene polymorphism and schizophrenia. Relation to tardive dyskinesia. Neuropsychopharmacol 2000, 23:170-177
12. Van Landeghem GF, Tabatabaie P, Beckman G, Beckman L, Andersen PM: Manganese-containing superoxide dismutase signal sequence polymorphism associated with sporadic motor neuron disease. Eur J Neurol 1999, 6:639-644
13. Hiroi S, Harada H, Nishi H, Satoh M, Nagai R, Kimura A: Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun 1999, 261:332-339
14. Borgstahl GE, Parge HE, Hickey MJ, Johnson MJ, Boissinot M, Hallewell RA, Lepock JR, Cabelli DE, Tainer JA: Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface. Biochemistry 1996, 35:4287-4297
15. Checkoway H, Farin FM, Costa-Mallen P, Kirchner SC, Costa LG: Genetic polymorphisms in Parkinson's disease. Neurotoxicology 1998, 19:635-643
16. Grasbon-Frodl EM, Kosel S, Riess O, Muller U, Mehraein P, Graeber MB: Analysis of mitochondrial targeting sequence and coding region polymorphisms of the manganese superoxide dismutase gene in German Parkinson disease patients. Biochem Biophys Res Commun 1999, 255:749-752
17. Sandstrom J, Nilsson P, Karlsson K, Marklund SL: 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem 1994, 269:19163-19166
18. Yamada H , Yamada Y, Adachi T, Goto H, Ogasawara N, Futenma A, Kitano M, Hirano K, Kato K: Molecular analysis of extracellular-superoxide dismutase gene associated with high level in serum. Jpn J Hum Genet 1995, 40:177-184
19. Yamada H , Yamada Y, Adachi T, Goto H, Ogasawara N, Futenma A, Kitano M, Miyai H, Fukatsu A, Hirano K, Kakumu S: Polymorphism of extracellular superoxide dismutase (EC-SOD) gene: relation to the mutation responsible for high EC-SOD level in serum. Jpn J Hum Genet 1997, 42:353-356
20. Adachi T, Wang XL: Association of extracellular-superoxide dismutase phenotype with the endothelial constitutive nitric oxide synthase polymorphism. FEBS Lett 1998, 433:166-168
21. Marklund SL, Nilsson P, Israelsson K, Schampi I , Peltonen M , Asplund K: Two variants of extracellular-superoxide dismutase: relationship to cardiovascular risk factors in an unselected middle-aged population. J Intern Med 1997, 242:5-14
22. Sakashita N, Ando Y, Marklund SL, Nilsson P, Tashima K, Yamashita T, Takahashi K: Familial amyloidotic polyneuropathy type I with extracellular superoxide dismutase mutation: a case report. Hum Pathol 1998, 29:1169-1172
23. Mathew CGP: The isolation of high molecular weight eukaryotic DNA. In Methods of Molecular Biology. Edited by Walker J. Vol. 2. Humana Press, 1984, 31-34
24. Budowle B, Chakraborty R , Giusti AM, Eisenberg AJ, Allen RC: Analysis of the VNTR locus D1S80 by PCR followed by high-resolution PAGE. Am J Hum Genet 1991, 48:137-144
25. Roff DA, Bentzen P: The statistical analysis of mitochondrial DNA polymorphisms: X2 and the problem of small samples. Mol Biol Evol 1989, 6:539-545
26. Church SL, Grant JW, Meese EU, Trent JM: Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD/SOD2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping. Genomics 1992, 14:823-825
27. Caulfield M, Lavender P, Farral M, Nunroe P, Lawson M, Turner P, Clark AJI: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994, 330:1629-1633
28. Hingorani A, Brown MJ: A simple molecular assay for the C1166 variant of the angiotensin II type 1 receptor gene. Biochem Biophys Res Commun 1995, 213:725-729
29. Van Landeghem GF, Tabatabaie P, Kucinskas V, Saha N, Beckman G: Ethnic variation in the mitochondrial targeting sequence polymorphism of MnSOD. Hum Hered 1999, 49:190-193
30. Shimoda-Matsubayashi S, Hattori Y, Matsumine H, Shinohara A, Yoritaka A, Mori H, Kondo T, Chiba M, Mizuno Y: MnSOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control. Neurology 1997, 49:1257-1262
31. Jenner P: Oxidative stress in Parkinson's disease and other neurodegenerative disorders. Pathol Biol (Paris) 1996, 44:57-64
32. Melov S, Schneider J, Day B, Hinerfield D, Coscun P, Mirra SS, Crapo ID, Wallace DC: A novel neurological phenotype in mice lacking mitochondrial superoxide dismutase. Nat Genet 1998, 18:159-163
33. Adachi T, Yamada H, Yamada Y, Morihara N, Yamazaki N, Murakami T, Futenma A, Kato K, Hirano K: Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface. Biochem J 1996, 313:235-239